HCWB - HCW Biologics Inc.
Previous close
0.4226
-0.007 -1.751%
Share volume: 503
Last Updated: Fri 27 Dec 2024 08:14:44 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$0.43
-0.01
-1.72%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-12 | 2022-11-07 | 2023-03-28 | 2023-05-09 | 2023-08-11 | 2023-11-14 | 2024-05-15 | 2024-05-15 | |
| Total revenue | 454.000 K | 1.809 M | 1.342 M | 41.883 K | 622.807 K | 853.102 K | 1.324 M | 1.127 M | |
| Cost of revenue | 287.200 K | 1.447 M | 1.073 M | 29.350 K | 502.402 K | 678.325 K | 1.071 M | 0.000 | |
| Gross profit | 166.800 K | 361.805 K | 268.304 K | 12.533 K | 120.405 K | 174.777 K | 252.645 K | 1.127 M | |
| 116.91% | -25.84% | -95.33% | 860.70% | 45.16% | 44.55% | 345.97% | |||
| Operating expenses | 3.678 M | 4.381 M | 5.936 M | 5.373 M | 4.631 M | 5.253 M | 5.771 M | 8.108 M | |
| Selling general and admin | 1.708 M | 1.733 M | 3.006 M | 3.117 M | 3.014 M | 3.585 M | 3.634 M | 5.985 M | |
| Research and development | 1.970 M | 2.649 M | 2.930 M | 2.256 M | 1.617 M | 1.667 M | 2.136 M | 2.123 M | |
| Total expenses | 3.965 M | 5.829 M | 7.009 M | 5.402 M | 5.133 M | 5.931 M | 12.092 M | 8.620 M | |
| 47.00% | 20.25% | -22.92% | -4.98% | 15.54% | 103.88% | -28.71% | |||
| Operating income | -3.511 M | -4.020 M | -5.667 M | -5.361 M | -4.511 M | -5.078 M | -10.768 M | -7.494 M | |
| Ebit | -3.511 M | -4.020 M | -5.667 M | -5.361 M | -4.511 M | -5.078 M | -10.768 M | -7.494 M | |
| Pretax income | -3.511 M | -3.914 M | -5.419 M | -5.071 M | -4.304 M | -4.939 M | -10.681 M | -7.468 M | |
| 11.50% | 38.44% | -6.42% | -15.11% | 14.73% | 116.26% | -30.08% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -3.511 M | -3.914 M | -5.419 M | -5.071 M | -4.304 M | -4.939 M | -10.681 M | -7.468 M | |
| -11.50% | -38.44% | 6.42% | 15.11% | -14.73% | -116.26% | 30.08% | |||
| Net income | -3.511 M | -3.914 M | -5.419 M | -5.071 M | -4.304 M | -4.939 M | -10.681 M | -7.468 M | |
| -11.50% | -38.44% | 6.42% | 15.11% | -14.73% | -116.26% | 30.08% |